Insider Transactions Reported by 17 Insiders of Denali Therapeutics Inc.

Symbol
DNLI on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Denali Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BAKER BROS. ADVISORS LP Director $510,833,810 +$39,977,138 +8.5% 11 Dec 2025
ROBERT NELSEN Director $178,327,354 02 Jun 2021
Ryan J. Watts President and CEO, Director $40,438,097 -$8,009,997 -17% 06 Jan 2026
Marc Tessier-Lavigne Director $34,909,435 03 Jun 2025
Steve E. Krognes Director $13,375,435 03 Jun 2025
Schuth Alexander O. COFO and Secretary $13,313,967 -$323,981 -2.4% 06 Jan 2026
FLATLEY JAY T. Director $5,795,641 03 Jun 2025
Carole Ho Chief Medical Officer $3,533,804 -$51,684 -1.4% 12 Aug 2025
VICKI L. SATO Director $2,257,778 02 Jan 2025
David P. Schenkein Director $764,279 03 Jun 2025
Douglas G. Cole Director $489,309 01 Jun 2023
Peter S. Klein Director $452,642 03 Jun 2025
Jennifer E. Cook Director $428,673 03 Jun 2025
Nancy Thornberry Director $406,347 03 Jun 2025
Erik Harris Director $347,690 31 May 2024
Timothy Van Hauwermeiren Director $154,376 04 Nov 2025
Julian C. Baker Director 03 Jun 2025

Recent Insider Transactions by Companies or Individuals for Denali Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.